AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3524509 — intervention group
Group type: COMPARATOR
Intervention: Lactose (placebo)
Number of subjects: 30
Study 30466144 — intervention group
Group type: EXPERIMENTAL
Intervention: Soap bubble protocol
Number of subjects: 74
Study 30466144 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study 29128692 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 975 mg tid and omeprazole 20 mg od
Number of subjects: 94
Study 29128692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 26155004 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% papain gel
Number of subjects: 18
Study 26155004 — intervention group
Group type: COMPARATOR
Intervention: 2% carboxymethyl cellulose gel
Number of subjects: 18
Study 24231646 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus/Mycophenolate Mofetil (Tac/MMF)
Number of subjects: 307
Study 24231646 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine/Azathioprine (CsA/AZA)
Number of subjects: 307
Study 21814138 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant GH (rGH) administration, 6 IU daily
Number of subjects: 12
Study 19487903 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonnucleoside reverse transcriptase inhibitor (NNRTI) + protease inhibitor
Number of subjects: 0
Study 19487903 — intervention group
Group type: COMPARATOR
Intervention: Classical nucleoside reverse transcriptase inhibitor (NRTI) based regimen
Number of subjects: 0
Study 16877196 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention to promote motivation for weight loss
Number of subjects: 0
Study 16877196 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention fidelity criteria
Number of subjects: 0
Study 15488341 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylphenidate (MPH) 0.5 mg/kg
Number of subjects: 11
Study 11681631 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acids (MUFA) diet
Number of subjects: 0
Study 11681631 — intervention group
Group type: COMPARATOR
Intervention: Control diet (not specified)
Number of subjects: 0
Study 9475306 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice oral rehydration solution (ORS)
Number of subjects: 0
Study 9475306 — intervention group
Group type: COMPARATOR
Intervention: Glucose oral rehydration solution (ORS)
Number of subjects: 0
Study 7524313 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh frozen plasma (FFP) 20 ml/kg
Number of subjects: 8
Study 2856598 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirprofen administered by iontophoresis
Number of subjects: 80
Study 2856598 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine soluble aspirin administered by iontophoresis
Number of subjects: 80
Study 31758375 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU/day of vitamin D for 10 days
Number of subjects: 20
Study 31758375 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU/day of vitamin D for 10 days
Number of subjects: 20
Study 29659658 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week low-fat diet (<20% of energy from fat)
Number of subjects: 88
Study 29659658 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week high-fat diet (>35% of energy from fat)
Number of subjects: 88
Study 29659658 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (n=32)
Number of subjects: 88
Study 29659658 — intervention group
Group type: COMPARATOR
Intervention: High-fat diet (n=35)
Number of subjects: 88
Study 29659658 — intervention group
Group type: EXPERIMENTAL
Intervention: Heritability of baseline FT rank
Number of subjects: 88
Study 28954802 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate discharge (n=53)
Number of subjects: 105
Study 28954802 — intervention group
Group type: COMPARATOR
Intervention: Management in an observation unit with stress testing (n=52)
Number of subjects: 105
Study 28954802 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (n=105)
Number of subjects: 105
Study 25672646 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowel preparation (n = 60)
Number of subjects: 121
Study 25672646 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 61)
Number of subjects: 121
Study 23534020 — intervention group
Group type: EXPERIMENTAL
Intervention: MDPB-containing adhesive system (Clearfil Protect Bond)
Number of subjects: 40
Study 23534020 — intervention group
Group type: COMPARATOR
Intervention: MDPB-free self-etching adhesive system (Clearfil SE Bond)
Number of subjects: 40
Study 23534020 — intervention group
Group type: EXPERIMENTAL
Intervention: MDPB-containing self-etching primer with fluoride-free bonding agent
Number of subjects: 40
Study 23534020 — intervention group
Group type: COMPARATOR
Intervention: MDPB-free self-etching primer with fluoride-containing bonding agent
Number of subjects: 40
Study 23534020 — intervention group
Group type: COMPARATOR
Intervention: Three-step etch-and-rinse adhesive system (Adper Scotchbond Multi Purpose)
Number of subjects: 40
Study 21739688 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at C4‐C7 Jiaji (EX‐B 2) for 5 min
Number of subjects: 32
Study 21739688 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforcing and reducing method (not specified if control or intervention)
Number of subjects: 32
Study 21739688 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint selection (C4‐C7 Jiaji (EX‐B 2) and others)
Number of subjects: 32
Study 21739688 — intervention group
Group type: EXPERIMENTAL
Intervention: Time of needle retaining (5 min, 15 min)
Number of subjects: 32
Study 19067055 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic long shears (H-LS)
Number of subjects: 161
Study 19067055 — intervention group
Group type: COMPARATOR
Intervention: Regular harmonic shears (HS)
Number of subjects: 161
Study 19067055 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 161
Study 16434457 — intervention group
Group type: COMPARATOR
Intervention: Glucose preload (1 MJ)
Number of subjects: 19
Study 16434457 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein preloads (whey, casein)
Number of subjects: 19
Study 16434457 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey preload
Number of subjects: 19
Study 16434457 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose preload
Number of subjects: 19
Study 16434457 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein preload
Number of subjects: 19
Study 14688031 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone exposure (300 parts/billion)
Number of subjects: 16
Study 14688031 — intervention group
Group type: COMPARATOR
Intervention: Clean air (control)
Number of subjects: 16
Study 14688031 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (oxidants)
Number of subjects: 16
Study 14688031 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamins (antioxidants)
Number of subjects: 16
Study 11768323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 11768323 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 600mg
Number of subjects: 12
Study 11768323 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 1200mg
Number of subjects: 12
Study 9390976 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise (80% maximal O2 uptake, n = 12)
Number of subjects: 26
Study 9390976 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (50% maximal O2 uptake, n = 14)
Number of subjects: 26
Study 9390976 — intervention group
Group type: EXPERIMENTAL
Intervention: Training (3 times per week for 24 weeks)
Number of subjects: 26
Study 8355740 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound screening (2.2 sonograms per woman)
Number of subjects: 15151
Study 8355740 — intervention group
Group type: COMPARATOR
Intervention: Control group (0.6 sonograms per woman)
Number of subjects: 15151
Study 8355740 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound screening
Number of subjects: 15151
Study 3396545 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% with adrenaline 1:200,000 (Group 1)
Number of subjects: 13
Study 3396545 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% with adrenaline 1:200,000 (Group 2)
Number of subjects: 13
Study 30623078 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung function tests ('tests now' group)
Number of subjects: 674
Study 30623078 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control ('waiting list' group)
Number of subjects: 674
Study 27025240 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitor letrozole (Lz; 2.5 mg/day; n = 16)
Number of subjects: 30
Study 27025240 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl; n = 14)
Number of subjects: 30
Study 27025240 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Lz and Pl)
Number of subjects: 30
Study 25402401 — intervention group
Group type: EXPERIMENTAL
Intervention: $5, $10, or $20 for FOBT completion (Stage 1)
Number of subjects: 1549
Study 25402401 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 in 10 chance of $50 for FOBT completion (Stage 2)
Number of subjects: 1549
Study 25402401 — intervention group
Group type: COMPARATOR
Intervention: $5 fixed payment for FOBT completion (Stage 2)
Number of subjects: 1549
Study 25402401 — intervention group
Group type: COMPARATOR
Intervention: Entry into a $500 raffle for FOBT completion (Stage 2)
Number of subjects: 1549
Study 24037226 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES) 130/0.42
Number of subjects: 798
Study 24037226 — intervention group
Group type: COMPARATOR
Intervention: Ringer's acetate
Number of subjects: 798
Study 21136235 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management program FIBS (six modules including information about fatigue and behavioral therapy strategies)
Number of subjects: 0
Study 18444448 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous parecoxib 40 mg
Number of subjects: 55
Study 18444448 — intervention group
Group type: COMPARATOR
Intervention: Rectal diclofenac 100 mg
Number of subjects: 55
Study 22980293 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramyocardial injections of autologous bone-marrow derived mesenchymal stromal cells (MSCs)
Number of subjects: 60
Study 22980293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 16444382 — intervention group
Group type: COMPARATOR
Intervention: Norfloxacin (400 mg daily)
Number of subjects: 57
Study 16444382 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim‐sulfamethoxazole (800/160 mg/day, 5 days a week)
Number of subjects: 57
Study 12445024 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 1 h infusion of E7070
Number of subjects: 75
Study 12445024 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily 1 h infusion of E7070 for 5 days
Number of subjects: 75
Study 9462603 — intervention group
Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 2058
Study 9462603 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2058
Study 8534643 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate drops
Number of subjects: 104
Study 8534643 — intervention group
Group type: COMPARATOR
Intervention: Control medication
Number of subjects: 104
Study 11527119 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (Bi, n = 26)
Number of subjects: 56
Study 11527119 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (En, n = 30)
Number of subjects: 56
Study 370938 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG
Number of subjects: 33
Study 370938 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 33
Study 12364304 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 786
Study 12364304 — intervention group
Group type: COMPARATOR
Intervention: Monthly telephone contact
Number of subjects: 786
Study 12364304 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy plus telephone contact
Number of subjects: 786
Study 12364304 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 786
Study 30932787 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude palm oil fortified cookies (providing 2152 μg of β-carotene)
Number of subjects: 444
Study 30932787 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude palm oil fortified cookies
Number of subjects: 444
Study 30932787 — intervention group
Group type: COMPARATOR
Intervention: Placebo cookies (non-fortified)
Number of subjects: 444
Study 30342554 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM) therapy - 16 mg per day (8 mg twice daily, days 1 to 4), halved every 3 days until 0.5 mg a day on day 19, stopped on day 20.
Number of subjects: 420
Study 30342554 — intervention group
Group type: COMPARATOR
Intervention: Burr-hole craniotomy (BHC) - standard surgical intervention.
Number of subjects: 420
Study 26407272 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalent rLP2086 (3 doses)
Number of subjects: 0
Study 26407272 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalent rLP2086 (2 doses)
Number of subjects: 0
Study 26407272 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalent rLP2086 (2 or 3 doses)
Number of subjects: 0
Study 25211490 — intervention group
Group type: EXPERIMENTAL
Intervention: ReLEx smile
Number of subjects: 47
Study 25211490 — intervention group
Group type: COMPARATOR
Intervention: FS-LASIK
Number of subjects: 47
Study 22378724 — intervention group
Group type: EXPERIMENTAL
Intervention: UNIMMAP
Number of subjects: 1294
Study 22378724 — intervention group
Group type: COMPARATOR
Intervention: IFA
Number of subjects: 1294
Study 20465648 — intervention group
Group type: EXPERIMENTAL
Intervention: 20mg isotretinoin, 3 times per week, nightly moisturizer, and daily sunscreen for three months
Number of subjects: 32
Study 20465648 — intervention group
Group type: COMPARATOR
Intervention: Moisturizer and sunscreen
Number of subjects: 32
Study 18022044 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped-care intervention group (12 weeks of optimized antidepressant management followed by six sessions of a pain self-management program)
Number of subjects: 500
Study 18022044 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 500
Study 15983242 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (32 mg once daily)
Number of subjects: 5436
Study 15983242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5436
Study 15983242 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 5436
Study 12551867 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine infusion (0.125 g/min) for 120 minutes
Number of subjects: 9
Study 12551867 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion for 120 minutes
Number of subjects: 9
Study 10778516 — intervention group
Group type: COMPARATOR
Intervention: High dose (2 vials over 1 hour, followed by 2 vials over 4 hours, repeated 4 hourly until clotting parameters normalized and then 2 vials as infusion over 24 hours)
Number of subjects: 60
Study 10778516 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose (2 vials over 1 hour, followed by 1 vial over four hours, repeated 4 hourly until clotting parameters normalized and then 1 vial as infusion over 24 hours)
Number of subjects: 60
Study 8657463 — intervention group
Group type: EXPERIMENTAL
Intervention: Scanning started at 80% of the contrast injection time
Number of subjects: 45
Study 8657463 — intervention group
Group type: EXPERIMENTAL
Intervention: Scanning started at 100% of the contrast injection time
Number of subjects: 45
Study 8657463 — intervention group
Group type: EXPERIMENTAL
Intervention: Scanning started at 150% of the contrast injection time
Number of subjects: 45
Study 2050170 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine (25‐50 mg t.i.d.)
Number of subjects: 0
Study 2050170 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (0.25‐0.75 mg t.i.d.)
Number of subjects: 0
Study 2050170 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6353430 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg feprazone 3-times a day
Number of subjects: 200
Study 6353430 — intervention group
Group type: COMPARATOR
Intervention: 200 mg feprazone twice a day
Number of subjects: 200
Study 31486072 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management intervention (n = 232)
Number of subjects: 453
Study 31486072 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual or wait-list control (n = 221)
Number of subjects: 453
Study 29786898 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Prolonged Exposure (mPE) therapy for PTSD
Number of subjects: 126
Study 29786898 — intervention group
Group type: COMPARATOR
Intervention: Non-trauma-focused comparison treatment
Number of subjects: 126
Study 27273910 — intervention group
Group type: EXPERIMENTAL
Intervention: Free lutein (10 mg daily for 3 months)
Number of subjects: 20
Study 27273910 — intervention group
Group type: COMPARATOR
Intervention: Lutein esters (20 mg daily for 3 months, equivalent to 10 mg of free lutein)
Number of subjects: 20
Study 24287601 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of siltuximab
Number of subjects: 0
Study 24287601 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of siltuximab (predicted)
Number of subjects: 0
Study 24287601 — intervention group
Group type: EXPERIMENTAL
Intervention: Free IL-6 concentration change from baseline
Number of subjects: 0
Study 22169459 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 91
Study 22169459 — intervention group
Group type: COMPARATOR
Intervention: Parenteral Nutrition (PN)
Number of subjects: 91
Study 19874316 — intervention group
Group type: EXPERIMENTAL
Intervention: Undecylenoyl phenylalanine 2%
Number of subjects: 36
Study 19874316 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 36
Study 19874316 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient assessment ratings
Number of subjects: 36
Study 19874316 — intervention group
Group type: EXPERIMENTAL
Intervention: Side effects of active treatment
Number of subjects: 36
Study 17062659 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (walking, n = 20)
Number of subjects: 38
Study 17062659 — intervention group
Group type: COMPARATOR
Intervention: Placebo (low‐intensity stretching and relaxation exercises, n = 18)
Number of subjects: 38
Study 16170758 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination antiretroviral therapy
Number of subjects: 228
Study 16170758 — intervention group
Group type: COMPARATOR
Intervention: Decrease or no change in CD4+ cell count
Number of subjects: 228
Study 16170758 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4+ cell count increase ≥100-cell/mm3
Number of subjects: 228
Study 12366423 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacalcitol plus PUVA
Number of subjects: 31
Study 12366423 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene plus PUVA
Number of subjects: 31
Study 12366423 — intervention group
Group type: COMPARATOR
Intervention: PUVA monotherapy
Number of subjects: 31
Study 10544415 — intervention group
Group type: EXPERIMENTAL
Intervention: Relearning group (correct KR after 125 trials of erroneous KR)
Number of subjects: 26
Study 10544415 — intervention group
Group type: COMPARATOR
Intervention: Erroneous KR group
Number of subjects: 26
Study 10544415 — intervention group
Group type: COMPARATOR
Intervention: No-KR group
Number of subjects: 26
Study 7646670 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol
Number of subjects: 80
Study 7646670 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipivefrine
Number of subjects: 80
Study 7646670 — intervention group
Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 80
Study 1976738 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurolept anaesthesia
Number of subjects: 26
Study 1976738 — intervention group
Group type: COMPARATOR
Intervention: Enflurane/N2O
Number of subjects: 26
Study 376030 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study 376030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30267277 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser irradiation (L)
Number of subjects: 240
Study 30267277 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride treatment (F)
Number of subjects: 240
Study 30267277 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined fluoride and laser treatment (FL)
Number of subjects: 240
Study 30267277 — intervention group
Group type: COMPARATOR
Intervention: No treatment, control (C)
Number of subjects: 240
Study 27965285 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenecteplase
Number of subjects: 146
Study 27965285 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenecteplase (in patients with target mismatch)
Number of subjects: 146
Study 27965285 — intervention group
Group type: COMPARATOR
Intervention: Alteplase
Number of subjects: 146
Study 26184292 — intervention group
Group type: EXPERIMENTAL
Intervention: Highland barley (HB) load
Number of subjects: 50
Study 26184292 — intervention group
Group type: COMPARATOR
Intervention: Glucose (GL) load
Number of subjects: 50
Study 26184292 — intervention group
Group type: COMPARATOR
Intervention: White rice (WR) load
Number of subjects: 50
Study 24039148 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPPV
Number of subjects: 179
Study 24039148 — intervention group
Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 179
Study 22474057 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamins (2 mg folic acid, 25 mg vitamin B(6), 500 μg vitamin B(12))
Number of subjects: 8164
Study 19387377 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance only (R)
Number of subjects: 30
Study 19387377 — intervention group
Group type: COMPARATOR
Intervention: Resistance + cycle ergometry (RC)
Number of subjects: 30
Study 19387377 — intervention group
Group type: COMPARATOR
Intervention: Resistance + incline treadmill (RT)
Number of subjects: 30
Study 17599576 — intervention group
Group type: EXPERIMENTAL
Intervention: Expansion sphincter pharyngoplasty (ESP)
Number of subjects: 45
Study 17599576 — intervention group
Group type: COMPARATOR
Intervention: Uvulopalatopharyngoplasty (Control)
Number of subjects: 45
Study 14991555 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose syrup (routine administration twice daily)
Number of subjects: 0
Study 14991555 — intervention group
Group type: COMPARATOR
Intervention: Standard care (laxative on indication)
Number of subjects: 0